Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 902219 Boston, MA

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
695,848
+8.5% QoQ
Ownership
0.270%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 0% Shared 71% None 29%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $2,155,261,599 across 33 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 695,848
2025-12-31 641,178
2025-09-30 681,294
2025-03-31 761,980
2024-12-31 560,276
2024-09-30 602,936
2024-06-30 361,424
2024-03-31 360,827
2023-03-31 236,874
2022-12-31 245,074
2022-09-30 274,425
2022-06-30 292,778
2022-03-31 292,778
2021-12-31 218,320